PDSS2 and Prostate

Published: 11 February 2021| Version 1 | DOI: 10.17632/cfc4fbdxg5.1
Contributor:
CARLOS HIRTH

Description

In this study we tested the notion that PDSS2 expression is greater in non-neoplastic prostate tissue than in neoplastic tissue and that PDSS2-positive neoplasms are relatively indolent due to the maintenance of the mitochondrial pathway. To do so, we submitted neoplastic and non-neoplastic tissues to immunohistochemistry in search for possible associations between PDSS2 positivity and biochemical persistence, biochemical recurrence and biochemical failure after adjuvant therapy and radio/hormone salvage therapy

Files

Steps to reproduce

This Data are in SPSS36 format